Secondary Pasteurella multocida Infection Complicating Allergic Bronchopulmonary Aspergillosis During Dupilumab Therapy: A Case Report
Respirology Case Reports · 2026-11 · 14 (11)
DOI: 10.1002/rcr2.70807 ↗Abstract
ABSTRACT We report the case of a 54‐year‐old woman with asthma, eosinophilic chronic rhinosinusitis, eosinophilic gastroenteritis and allergic bronchopulmonary aspergillosis (ABPA). She had long‐term cat exposure and received low‐dose prednisolone. Chest computed tomography showed mucus plugging in the right middle and left upper lobes, and laboratory findings showed eosinophilia, elevated serum immunoglobulin E (IgE), and positive Aspergillus ‐specific IgE and IgG. Following initiation of dupilumab to minimize systemic corticosteroid exposure, ABPA, sinonasal disease and lung function improved. Fourteen months later, a new opacity appeared in a bronchiectatic lesion of the right middle lobe, raising concern for ABPA relapse. Bronchoscopy revealed purulent secretions, and Pasteurella multocida ( P. multocida ) was isolated from bronchoscopic specimens, supporting secondary bacterial infection. The infection improved with antimicrobial therapy. Dupilumab was continued, and oral corticosteroids were eventually discontinued without recurrence of infection. This case highlights the importance of distinguishing secondary infection from ABPA relapse when new opacities develop during biologic therapy.
EUVIMED